Hashemipour Mahin, Hovsepian Silva, Ansari Arman, Keikha Mojtaba, Khalighinejad Pooyan, Niknam Negar
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Emam Hossein Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Pediatr Neonatol. 2018 Feb;59(1):3-14. doi: 10.1016/j.pedneo.2017.04.006. Epub 2017 Jul 22.
Evidence from different screening programs indicated that the rate of congenital hypothyroidism (CH) was higher in pre-term and low-birth-weight (LBW) newborns than normal ones. Incomplete development of hypothalamic-pituitary axis in this group of neonates results in the delayed rise of TSH and missing cases with CH. Hence, there is a great need for a practicable systematic screening method for proper diagnosis of CH in this group of neonates. In this review, we systematically reviewed papers with the following key words ([Congenital Hypothyroidism AND Screening AND Thyroxine AND Thyroid Stimulating Hormone AND Low Birth Weight AND Premature]) in international electronic databases including PubMed, Scopus, and Google Scholar. After quality assessment of selected documents, data of finally included papers were extracted. In this review, 1452 papers (PubMed: 617; Scopus: 714; Google scholar: 121) were identified through electronic database search. One hundred and ninety four articles were assessed for eligibility, from which 36 qualified articles were selected for final evaluation. From the reviewed articles, 38.9%, 11.11% and 8.3% recommended rescreening in this group of neonates, lowering the screening cutoff of TSH and using cutoffs according to the gestational age, respectively. Some of them (13.9%) recommended using both TSH and T4 for screening of preterm infants. After reviewing available data, we recommend repeating the screening test in pre-term, LBW and very-low- birth-weight (VLBW) infants at age of two, six and ten weeks by measuring TSH and FT4 levels simultaneously and considering TSH = 10 mU/L as the cutoff level for positive and suspicious cases.
来自不同筛查项目的证据表明,早产和低出生体重新生儿的先天性甲状腺功能减退症(CH)发病率高于正常新生儿。这组新生儿下丘脑 - 垂体轴发育不全导致促甲状腺激素(TSH)升高延迟以及CH漏诊病例。因此,迫切需要一种切实可行的系统筛查方法,以便对这组新生儿的CH进行正确诊断。在本综述中,我们在包括PubMed、Scopus和谷歌学术在内的国际电子数据库中,系统地检索了以下关键词([先天性甲状腺功能减退症 AND 筛查 AND 甲状腺素 AND 促甲状腺激素 AND 低出生体重 AND 早产])的论文。在对选定文献进行质量评估后,提取了最终纳入论文的数据资料。在本综述中,通过电子数据库检索共识别出1452篇论文(PubMed:617篇;Scopus:714篇;谷歌学术:121篇)。对194篇文章进行了资格评估,从中选出36篇合格文章进行最终评价。在这些综述文章中,分别有38.9%、11.11%和8.3%建议对这组新生儿进行重新筛查、降低TSH筛查临界值以及根据胎龄使用临界值。其中一些文章(13.9%)建议同时使用TSH和T4对早产儿进行筛查。在审查现有数据后,我们建议在早产、低出生体重和极低出生体重(VLBW)婴儿2周、6周和10周龄时,同时检测TSH和FT4水平,并将TSH = 10 mU/L作为阳性和可疑病例的临界值,重复进行筛查试验。